What medication is effective for treating itching and burning feet?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 3, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment for Itching and Burning Feet

For itching and burning feet, start with topical high-potency corticosteroids (mometasone furoate 0.1% or betamethasone valerate 0.1% ointment) applied twice daily, combined with urea 10% cream at least twice daily for skin barrier repair. 1

First-Line Topical Therapy

Topical corticosteroids are the cornerstone of treatment:

  • Apply moderate-to-high potency topical corticosteroids (mometasone furoate 0.1% ointment or betamethasone valerate 0.1% ointment) twice daily to affected areas 1
  • Hydrocortisone 2.5% has been shown to significantly decrease experimentally-induced pruritus compared to placebo 1
  • For mild symptoms, over-the-counter hydrocortisone 1% cream can provide anti-itch relief 2

Add emollients and barrier repair agents:

  • Apply urea 10% cream at least twice daily to prevent and treat dry skin, which exacerbates itching 1, 3
  • Lotions containing urea or polidocanol may soothe pruritus 1
  • Apply after bathing when skin is slightly damp for optimal absorption 3

Consider topical anesthetics for burning pain:

  • Lidocaine 5% patches or cream can be applied to painful areas for immediate relief 1
  • Topical antipruritic agents containing menthol 0.5% may provide cooling relief 1

Systemic Therapy for Moderate-to-Severe Symptoms

If topical therapy fails after 2 weeks, escalate to oral antihistamines:

  • Daytime: Non-sedating second-generation antihistamines (loratadine 10 mg daily) as first-choice systemic therapy 1
  • Nighttime: First-generation antihistamines (diphenhydramine 25-50 mg or hydroxyzine 25-50 mg) for their sedative properties to break the itch-scratch cycle 1

For refractory cases, consider GABA agonists as second-line:

  • Gabapentin 900-3600 mg daily (starting at 300 mg at bedtime) 1
  • Pregabalin 25-150 mg daily (or 75-300 mg every 12 hours) 1
  • These work by reducing peripheral release of calcitonin gene-related peptide and modulating central opioid receptors 1

Rule Out Specific Causes

Fungal infection (Tinea pedis/Athlete's foot):

  • If fine scaly eruption with fissures between toes is present, this is likely tinea pedis 1
  • Treat with terbinafine 1% cream daily for 1 week (mycological cure rate ~94%) 1
  • For extensive disease, oral terbinafine 250 mg once daily for 1 week provides faster clinical resolution 1
  • Apply foot powder after bathing to reduce recurrence from 8.5% to 2.1% 1, 4

Erythromelalgia (burning feet syndrome):

  • If burning pain with redness triggered by warmth, consider erythromelalgia 1
  • First-line: Topical amitriptyline-ketamine compound 1
  • Systemic: Gabapentin or pregabalin as outlined above 1

Critical Adjunctive Measures

Behavioral modifications:

  • Avoid mechanical stress (long walks without cushioned shoes) and chemical irritants (solvents, disinfectants) 1
  • Dry thoroughly between toes after showers 1
  • Change socks daily and periodically clean athletic footwear 1, 4
  • Avoid ice water immersion, which can worsen symptoms; limit cooling to 10 minutes at a time, maximum 4 times daily 1

Common Pitfalls to Avoid

Do not use topical corticosteroids if fungal infection is suspected, as they increase susceptibility to fungal infections and may worsen the condition 5

Do not assume treatment failure without reassessing after 2 weeks - if symptoms worsen or fail to improve with topical therapy, escalate to systemic treatment rather than continuing ineffective topical therapy 1

Do not treat feet in isolation - examine for concomitant nail fungus (onychomycosis), which serves as a reservoir for reinfection in tinea pedis 4

Avoid prolonged use of potent topical steroids without monitoring, especially in children who have proportionately greater percutaneous absorption 5

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Urea-Containing Lotions for Dry Skin

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Treatment of Refractory Extensive Athlete's Foot

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.